1-2 of 2
Caroline Ram-Wolff, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IPH4102; An Anti-KIR3DL2 Monoclonal Antibody in Refractory Sezary Syndrome: Results from a Multicenter Phase 1 Trial

Martine Bagot, MD PhD, Pierluigi Porcu, MD, Basem M. William, MRCP,MD, Maxime Battistella, MD PhD, Maarten Vermeer, MD PhD, Sean Whittaker, MD FRCP, Caroline Ram-Wolff, MD, Michael S Khodadoust, MDPhD, Helene Sicard, PhD, Hatem A Azim, Jr., MD PhD, Youn H. Kim, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 684.
https://doi.org/10.1182/blood-2018-99-118021
Published: 2018
Journal Articles

First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results

Martine Bagot, MD, Pierluigi Porcu, MD, Caroline Ram-Wolff, MD, Michael Khodadoust, MD PhD, Maxime Battistella, MD, Anne Marie-Cardine, PhD, Steve Mathieu, MD, Maarten H. Vermeer, MD PhD, Sean Whittaker, MB, ChB, FRCP, MD, Madeleine Duvic, MD, Armand Bensussan, PhD, Carine Paturel, PhD, Cecile Bonnafous, PhD, Nicolas Thonnart, Agnes Widemann, PharmD, Cecile Bonin, PharmD, Helene Sicard, PhD, Christine Paiva, Korinna Pilz, MD, Youn Kim, MD
Journal: Blood
Blood (2016) 128 (22): 1826.
https://doi.org/10.1182/blood.V128.22.1826.1826
Published: 2016